Showing results (141-150 of 1,035) with videos related to

Sort By:
Pageof 104
Statistics in Medicine|April 2, 2023
Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysisChristian Röver, Sibylle Sturtz, Jona Lilienthal, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 17, 2012
Time-patterns of annualized relapse rates in randomized placebo-controlled clinical trials in relapsing multiple sclerosis: a systematic review and meta-analysisRichard Nicholas, Sebastian Straube, Heinz Schmidli, et al.
Trials|June 1, 2024
Survival analysis for AdVerse events with VarYing follow-up times (SAVVY): summary of findings and assessment of existing guidelinesKaspar Rufibach, Jan Beyersmann, Tim Friede, et al.
JACC. Asia|May 14, 2025
Impact of Nonadherence to Any Antiplatelet Therapy After PCI With Drug-Eluting Stents on Critical OutcomesYuichiro Mori, Tim Friede, Satoshi Hattori, et al.
The Cochrane Database of Systematic Reviews|January 23, 2009
Anticholinergics for urinary symptoms in multiple sclerosisRichard S Nicholas, Tim Friede, Sally Hollis, et al.
ERJ Open Research|March 10, 2022
COPD mortality and exacerbations in the placebo group of clinical trials over two decades: a systematic review and meta-regressionStefan Andreas, Christian Röver, Judith Heinz, et al.
ESC Heart Failure|March 30, 2021
Effect of Carillon Mitral Contour System on patient-reported outcomes in functional mitral regurgitation: an individual participant data meta-analysisMuhammad Shahzeb Khan, Tim Friede, Stefan D Anker, et al.
Statistics in Medicine|March 25, 2020
Blinded sample size reestimation for negative binomial regression with baseline adjustmentAntonia Zapf, Thomas Asendorf, Christoph Anten, et al.
Pharmaceutical Statistics|May 18, 2021
Estimating and comparing adverse event probabilities in the presence of varying follow-up times and competing eventsRegina Stegherr, Claudia Schmoor, Michael Lübbert, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 19, 2011
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial designRichard Nicholas, Sebastian Straube, Heinz Schmidli, et al.
Pageof 104